Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model

Yun Zhai, Toru Yamashita, Yumiko Nakano, Zhuoran Sun, Jingwei Shang, Tian Feng, Ryuta Morihara, Yusuke Fukui, Yasuyuki Ohta, Nozomi Hishikawa, Koji Abe

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Recently, aging societies have been showing an increasingly strong relationship between Alzheimer's disease (AD) and chronic cerebral hypoperfusion (HP). In the present study, we created a new mouse model for AD with HP, and investigated its clinical and pathological characteristics. Alzheimer's disease transgenic mice (APP23) were subjected to bilateral common carotid arteries stenosis with ameroid constrictors for slowly progressive cerebral HP. In contrast to simple APP23 mice, cerebral HP exacerbated motor and cognitive dysfunctions with white matter lesions and meningo-parenchymal amyloid-β (Aβ) burdens. Strong cerebrovascular inflammation and severe amyloid angiopathy with cerebrovascular remodeling were also observed in APP23 HP mouse brains. An acetylcholinesterase inhibitor galantamine improved such clinical dysfunctions, retrieved above neuropathological characteristics, and enhanced nicotinic acetylcholine receptor (nAChR)-binding activity. The present study demonstrates that chronic cerebral HP enhanced cognitive/motor dysfunctions with parenchymal/cerebrovascular Aβ accumulation and cerebrovascular remodeling. These neuropathological abnormalities were greatly ameliorated by galantamine treatment associated with nAChR-mediated neuroprotection by allosterically potentiating ligand action.

Original languageEnglish
Pages (from-to)893-905
Number of pages13
JournalJournal of Alzheimer's Disease
Volume53
Issue number3
DOIs
Publication statusPublished - 2016

Fingerprint

Galantamine
Alzheimer Disease
Nicotinic Receptors
Pathology
Carotid Stenosis
Cholinesterase Inhibitors
Amyloid
Transgenic Mice
Ligands
Inflammation
Brain
Cognitive Dysfunction
ameroid
White Matter
Neuroprotection
Amyloid angiopathy

Keywords

  • Alzheimer's disease
  • APP23 mice
  • cerebral amyloid angiopathy
  • galantamine
  • hypoperfusion

ASJC Scopus subject areas

  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model. / Zhai, Yun; Yamashita, Toru; Nakano, Yumiko; Sun, Zhuoran; Shang, Jingwei; Feng, Tian; Morihara, Ryuta; Fukui, Yusuke; Ohta, Yasuyuki; Hishikawa, Nozomi; Abe, Koji.

In: Journal of Alzheimer's Disease, Vol. 53, No. 3, 2016, p. 893-905.

Research output: Contribution to journalArticle

Zhai, Yun ; Yamashita, Toru ; Nakano, Yumiko ; Sun, Zhuoran ; Shang, Jingwei ; Feng, Tian ; Morihara, Ryuta ; Fukui, Yusuke ; Ohta, Yasuyuki ; Hishikawa, Nozomi ; Abe, Koji. / Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model. In: Journal of Alzheimer's Disease. 2016 ; Vol. 53, No. 3. pp. 893-905.
@article{908e2fa722674f10ad084ea034e77ab4,
title = "Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model",
abstract = "Recently, aging societies have been showing an increasingly strong relationship between Alzheimer's disease (AD) and chronic cerebral hypoperfusion (HP). In the present study, we created a new mouse model for AD with HP, and investigated its clinical and pathological characteristics. Alzheimer's disease transgenic mice (APP23) were subjected to bilateral common carotid arteries stenosis with ameroid constrictors for slowly progressive cerebral HP. In contrast to simple APP23 mice, cerebral HP exacerbated motor and cognitive dysfunctions with white matter lesions and meningo-parenchymal amyloid-β (Aβ) burdens. Strong cerebrovascular inflammation and severe amyloid angiopathy with cerebrovascular remodeling were also observed in APP23 HP mouse brains. An acetylcholinesterase inhibitor galantamine improved such clinical dysfunctions, retrieved above neuropathological characteristics, and enhanced nicotinic acetylcholine receptor (nAChR)-binding activity. The present study demonstrates that chronic cerebral HP enhanced cognitive/motor dysfunctions with parenchymal/cerebrovascular Aβ accumulation and cerebrovascular remodeling. These neuropathological abnormalities were greatly ameliorated by galantamine treatment associated with nAChR-mediated neuroprotection by allosterically potentiating ligand action.",
keywords = "Alzheimer's disease, APP23 mice, cerebral amyloid angiopathy, galantamine, hypoperfusion",
author = "Yun Zhai and Toru Yamashita and Yumiko Nakano and Zhuoran Sun and Jingwei Shang and Tian Feng and Ryuta Morihara and Yusuke Fukui and Yasuyuki Ohta and Nozomi Hishikawa and Koji Abe",
year = "2016",
doi = "10.3233/JAD-160345",
language = "English",
volume = "53",
pages = "893--905",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model

AU - Zhai, Yun

AU - Yamashita, Toru

AU - Nakano, Yumiko

AU - Sun, Zhuoran

AU - Shang, Jingwei

AU - Feng, Tian

AU - Morihara, Ryuta

AU - Fukui, Yusuke

AU - Ohta, Yasuyuki

AU - Hishikawa, Nozomi

AU - Abe, Koji

PY - 2016

Y1 - 2016

N2 - Recently, aging societies have been showing an increasingly strong relationship between Alzheimer's disease (AD) and chronic cerebral hypoperfusion (HP). In the present study, we created a new mouse model for AD with HP, and investigated its clinical and pathological characteristics. Alzheimer's disease transgenic mice (APP23) were subjected to bilateral common carotid arteries stenosis with ameroid constrictors for slowly progressive cerebral HP. In contrast to simple APP23 mice, cerebral HP exacerbated motor and cognitive dysfunctions with white matter lesions and meningo-parenchymal amyloid-β (Aβ) burdens. Strong cerebrovascular inflammation and severe amyloid angiopathy with cerebrovascular remodeling were also observed in APP23 HP mouse brains. An acetylcholinesterase inhibitor galantamine improved such clinical dysfunctions, retrieved above neuropathological characteristics, and enhanced nicotinic acetylcholine receptor (nAChR)-binding activity. The present study demonstrates that chronic cerebral HP enhanced cognitive/motor dysfunctions with parenchymal/cerebrovascular Aβ accumulation and cerebrovascular remodeling. These neuropathological abnormalities were greatly ameliorated by galantamine treatment associated with nAChR-mediated neuroprotection by allosterically potentiating ligand action.

AB - Recently, aging societies have been showing an increasingly strong relationship between Alzheimer's disease (AD) and chronic cerebral hypoperfusion (HP). In the present study, we created a new mouse model for AD with HP, and investigated its clinical and pathological characteristics. Alzheimer's disease transgenic mice (APP23) were subjected to bilateral common carotid arteries stenosis with ameroid constrictors for slowly progressive cerebral HP. In contrast to simple APP23 mice, cerebral HP exacerbated motor and cognitive dysfunctions with white matter lesions and meningo-parenchymal amyloid-β (Aβ) burdens. Strong cerebrovascular inflammation and severe amyloid angiopathy with cerebrovascular remodeling were also observed in APP23 HP mouse brains. An acetylcholinesterase inhibitor galantamine improved such clinical dysfunctions, retrieved above neuropathological characteristics, and enhanced nicotinic acetylcholine receptor (nAChR)-binding activity. The present study demonstrates that chronic cerebral HP enhanced cognitive/motor dysfunctions with parenchymal/cerebrovascular Aβ accumulation and cerebrovascular remodeling. These neuropathological abnormalities were greatly ameliorated by galantamine treatment associated with nAChR-mediated neuroprotection by allosterically potentiating ligand action.

KW - Alzheimer's disease

KW - APP23 mice

KW - cerebral amyloid angiopathy

KW - galantamine

KW - hypoperfusion

UR - http://www.scopus.com/inward/record.url?scp=84981341446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981341446&partnerID=8YFLogxK

U2 - 10.3233/JAD-160345

DO - 10.3233/JAD-160345

M3 - Article

C2 - 27314529

AN - SCOPUS:84981341446

VL - 53

SP - 893

EP - 905

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -